Table 5.
Net league table of hyperkalemia.
| ACEI |
0.85 [0.14; 5.22 |
0.07 [0.01; 0.41] |
0.88 [0.39; 2.04] |
0.72 [0.47; 1.10] |
7.82 [0.37; 165.84] |
|||||
|
0.85 [0.14; 5.22] |
ACEI + CCB |
0.95 [0.36; 2.47] |
9.19 [0.40; 212.51] |
|||||||
|
0.27 [0.08; 0.87] |
0.32 [0.04; 2.74] |
ACEI + SPR |
1.72 [0.52; 5.76] |
|||||||
|
0.81 [0.10; 6.27] |
0.95 [0.36 2.47] |
2.99 [0.28; 41.67] |
ACEI + TZD | |||||||
|
0.77 [0.37; 1.62] |
0.90 [0.13; 6.42] |
2.85 [0.76; 10.72] |
0.95 [011; 8.45] |
ARB |
1.03 [0.48; 2.22] |
0.31 [0.03; 3.22] |
1.15 [0.48; 2.77] |
|||
|
0.72 [0.47; 1.10] |
0.85 [0.13; 5.47] |
2.68 [0.87; 8.28] |
0.90 [0.11; 7.27] |
0.94 [0.46; 1.93] |
ARB + ACEI | |||||
|
0.24 [0.02; 2.77] |
0.28 [0.01; 5.94] |
0.89 [0.06; 13.01] |
0.30 [0.01; 7.26] |
0.31 [0.03; 3.22] |
0.33 [0.03; 3.82] |
ARB + CCB |
8.09 [0.94; 69.21] |
7.54 [0.88; 64.56] |
||
|
0.89 [0.28; 2.80] |
1.04 [0.12; 8.93] |
3.29 [0.67; 16.11] |
1.10 [0.01; 11.55] |
1.15 [0.48; 2.77] |
1.23 [0.40; 3.82] |
3.69 [0.31; 44.42] |
ARB + RI | |||
|
7.82 [0.37; 165.84] |
9.19 [0.40; 212.51] |
29.02 [1.10; 763.07] |
9.71 [0.36; 258.71] |
10.18 [0.44; 235.83] |
510.84 [0.49; 236.51] |
32.52 [0.65; 1626.11] |
8.82 [0.34; 230.54] |
CCB | ||
|
1.95 [0.08; 50.36] |
2.29 [0.06; 94.86] |
7.22 [0.23; 223.64] |
2.41 [0.05; 113.02] |
2.53 [0.11; 60.13] |
2.69 [0.10; 69.39] |
8.09 [0.94; 69.217] |
2.19 [0.08; 58.72] |
0.25 [0.00; 21.56] |
CCB + BB |
0.93 [0.55; 15.70] |
|
1.81 [0.07; 46.98] |
2.13 [0.06; 88.48] |
6.73 [0.22; 208.60] |
2.25 [0.05; 105.42] |
2.36 [0.10; 56.08] |
2.51 [0.10; 64.72] |
7.54 [0.88; 64.56] |
2.05 [0.08; 54.78] |
0.23 [0.00; 20.11] |
0.93 [0.06; 15.70] |
CCB + TZD |
ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; BB, beta-blocker; CCB, calcium channel blockers; RI, renin inhibitor; SPR, spironolactone; TZD, thiazide diuretics.
Statistically significant values are expressed in bold.